JANX

Janux Therapeutics, Inc.NASDAQHealthcare

$14.84+2.27%ClosedMarket Cap: $902.7M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-27	Cantor Fitzgerald	—	Overweight	—
2026-02-27	Guggenheim	—	Buy	—
2026-01-20	Clear Street	—	Hold	—
2026-01-16	Piper Sandler	—	Overweight	—
2025-12-17	Barclays	—	Overweight	—
2025-12-02	Clear Street	—	Buy	—
2025-12-02	Stifel	—	Buy	—
2025-12-02	B of A Securities	—	Buy	—
2025-12-02	HC Wainwright & Co.	—	Buy	—
2025-12-02	Cantor Fitzgerald	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.33	$5.5M	12
Sun Dec 31	$-3.67	$39.0M	12
Mon Dec 31	$-3.49	$111.6M	10
Tue Dec 31	$-2.82	$232.9M	5